Clinical Trial Update: Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the immunogenicity and safety of a live varicella vaccine in healthy children aged 12-15 months in the Philippines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varicella Vaccine, Live (varicella vaccine, live)

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Varicella | Phase 3 | Status: COMPLETED